Last updated: July 11, 2026

Application No. 19/413,834

Untitled Application

Unknown

Filed

Priority

Oct 25, 2022 — provisional 63/419,155 +5 more

Examiner

HENLEY III, RAYMOND J

Art Unit

Tech Center

Veradermics, Incorporated

Assignee

VERADERMICS INCORPORATED

OA Round

1 (Non-Final)

Interview Optional

— +2.1% interview lift. Interview lift (+2.1%) is below the 15.0% threshold. A written response is recommended.

Based on 1252 resolved cases, 2023–2026

Examiner Intelligence

HENLEY III, RAYMOND J View full profile →

Grants 84% — above average

Career Allowance Rate

1045 granted / 1252 resolved

+23.5% vs TC avg

Minimal +2% lift

Without

With

+2.1%

Interview Lift

resolved cases with interview

Fast prosecutor

1y 10m

Avg Prosecution

43 currently pending

Career history

1290

Total Applications

across all art units

Statute-Specific Performance

§101

2.0%

-38.0% vs TC avg

§103

23.9%

-16.1% vs TC avg

§102

5.4%

-34.6% vs TC avg

§112

24.7%

-15.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1252 resolved cases

Prosecution Timeline

Apr 21, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

19/264,673

Patent 12629370

TREATMENT OF PROSTATE CANCER

10m to grant Granted May 19, 2026

19/229,702

Patent 12616752

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

11m to grant Granted May 05, 2026

19/206,788

Patent 12611416

METHODS OF TREATING ISCHEMIC STROKE AT RISK FOR CEREBRAL OR CEREBELLAR EDEMA

11m to grant Granted Apr 28, 2026

18/051,266

Patent 12605332

TRANSDERMAL DELIVERY FORMULATIONS

3y 5m to grant Granted Apr 21, 2026

18/266,345

Patent 12599604

APPLICATION OF JAK INHIBITOR IN KIDNEY DISEASE

2y 10m to grant Granted Apr 14, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

84%

Grant Probability

86%

With Interview (+2.1%)

1y 10m

Median Time to Grant

Low

PTA Risk

Based on 1252 resolved cases by this examiner. Grant probability derived from career allowance rate.